- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Tranzyme Pharma (NASDAQ:TZYM) Closing price $0.52
On Friday, Tranzyme reported the successful finalization of its chemistry-based drug discovery partnership with Bristol-Myers Squibb Company (NYSE:BMY). Resulting from their research efforts, the former has transferred compounds to the latter for further development across multiple drug targets. Through the accord, Tranzyme keeps the option to further pursue chosen collaboration targets for internal development.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.